Pernix Therapeutics Slashes Staff to Shake Up Sales Strategy
Xconomy
JULY 7, 2016
Pernix Therapeutics is slashing its headcount by more than 20 percent as the specialty pharmaceutical company tries to move toward profitability after a streak of acquisitions. As of the end of 2015, Pernix reported a headcount of 274. Those acquisitions helped Pernix reach $175.8 million net loss.
Let's personalize your content